www.taro.com

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

News Releases



Receive E-mail AlertsE-mail Alert Icon Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!

Search News Release

Date Title  
Toggle Summary Taro Reports Record Third Quarter and Nine-Month 2002 Results; 27th Consecutive Quarter of Record Sales 17th Consecutive Quarter of Record Net Income
HAWTHORNE, N.Y., Oct 24, 2002 (BUSINESS WIRE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq/NMS: TARO) 3rd Quarter 2002 Highlights: - Sales Increase 35% to $55.5 Million - Net Income Increases 58% to $11.6 Million, or $0.39 Per Diluted Share - Facility Acquired for New U.S.
Printer Friendly Version
Toggle Summary Taro Mourns Loss of Director Eric Hills
HAWTHORNE, N.Y., Oct 23, 2002 (BUSINESS WIRE) -- Taro Pharmaceutical Industries Ltd. (NASDAQ/NMS: TARO) today reported, with deep regret, the passing of Mr. Eric Hills, Vice Chairman of its Board of Directors, on Sunday, October 19, 2002. Mr. Hills died at the age of 80 from complications following
Printer Friendly Version
Terms of Use		 |
Privacy Statement		 |
Safe Harbor Statement